Effectiveness and Cost-Effectiveness of Endoscopic Screening And Surveillance
Overview
Pharmacology
Radiology
Authors
Affiliations
Guidelines for the screening and surveillance of Barrett's esophagus continue to evolve as the incidence of esophageal adenocarcinoma increases, identification of individuals at highest risk for cancer improves, and management of dysplasia evolves. This article reviews related studies and economic analyses. Advances in diagnosis offer promising strategies to help focus screening efforts on those individuals who are most likely to develop esophageal adenocarcinoma.
McKay S, DeSouza M, Dunst C, Reavis K, Bradley D, DeMeester S J Gastrointest Surg. 2023; 27(12):2711-2717.
PMID: 37932595 DOI: 10.1007/s11605-023-05874-8.
Rubenstein J, Omidvari A, Lauren B, Hazelton W, Lim F, Tan S Gastroenterology. 2022; 163(1):163-173.
PMID: 35364064 PMC: 10320713. DOI: 10.1053/j.gastro.2022.03.037.
Nguyen T, Thrift A, Ketwaroo G, Du X, Novelo L, George R Gastrointest Endosc. 2022; 95(6):1113-1122.
PMID: 34998796 PMC: 9119926. DOI: 10.1016/j.gie.2021.12.034.
Esophageal cancer: Epidemiology, risk factors and screening.
Li J, Xu J, Zheng Y, Gao Y, He S, Li H Chin J Cancer Res. 2021; 33(5):535-547.
PMID: 34815628 PMC: 8580797. DOI: 10.21147/j.issn.1000-9604.2021.05.01.
Frei N, Konte K, Bossart E, Stebbins K, Zhang Y, Pouw R Clin Transl Gastroenterol. 2020; 11(10):e00244.
PMID: 33108124 PMC: 7544172. DOI: 10.14309/ctg.0000000000000244.